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Abstract. Extensive research on the concept of mild cognitive impairment (MCI) as a potential prodromal stage of 
dementia has highlighted the likelihood that abnormalities in information processing occur at even earlier stages in the 
disease process with research increasingly focused on the relatively new concept of subjective cognitive impairment (SCI). 
An individual with SCI will experience cognitive impairment solely on a subjective level, which is in contrast to an 
individual with MCI who will also experience cognitive impairment at an objective level. SCI is believed to be a risk factor 
for development of MCI. This qualitative service evaluation aimed to determine how much is known about SCI and how it is 
currently managed in specialist clinical practice in the UK. An email-based questionnaire containing a vignette of an 
individual presenting with SCI was distributed to 112 memory clinics requesting information on their most likely approach 
to such an individual. The 21% response rate evinces potential time pressure within clinical services that may preclude 
research participation and/or a lack of issue salience at present. However, the data from those who responded provide an 
important insight into ‘where we are now’ in relation to this issue. Analysis revealed main themes associated with SCI, 
namely the factors that influence what action is taken when an individual presents and what further investigations are 
performed, the multiplicity of potential outcomes experienced, and the barriers clinicians may face. The findings highlight 
the need for a coherent and consistent framework in relation to the management of SCI. 
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INTRODUCTION 
 
Mild cognitive impairment (MCI) is a well-documented and clinically recognized potential prodromal stage of 
dementia [1, 2]. Subjective cognitive impairment (SCI), in which subjective changes in memory and cognition 
are reported in the absence of objective evidence of abnormality [3], has, however, received comparatively little 
attention. Although SCI is etiologically heterogeneous, individuals with this disorder are significantly more 
likely to decline to MCI or dementia diagnosis compared to demographically matched healthy adults free of 
SCI (hazard ratio 4.5; 95% CI 1.9–10.3), indicating that SCI often represents a harbinger of further decline [4]. 
Nevertheless, research and clinical practice in relation to prodromal dementia have tended to focus on MCI, 
despite indications that approximately 10% of adults aged 65 and above in the UK have MCI and 42% have 
self-reported memory complaints [5]. 
 
Irrespective of the increased risk for dementia, the assumption that SCI is benign and not associated with 
problems of significance is increasingly challenged. Irrespective of whether SCI represents an earlier prodromal 
stage of dementia or not, some individuals will suffer emotional distress because their concerns are not validated 
and they live with fear of significant underlying brain pathology and impending dementia. Concurrent mood 
disturbance and other reversible conditions may be overlooked and effective treatment denied. Quality of life 
may be significantly affected and perceived workplace performance impaired [6], social activities restricted, and 
driving avoided [7]. Furthermore, by the time a person with SCI who is on the Alzheimer’s disease (AD) 
pathway develops MCI, irreversible neuronal damage will have occurred [1, 8–10] and the potential benefit of 
disease-modifying treatment may already be reduced. Such research evidence suggests that effective 
intervention to delay or prevent decline may likely best be targeted at the earliest symptomatic stage of SCI, in 
which cognitive functioning is still relatively preserved. 
In parallel with this research-based evidence, the growing awareness of AD and associated disorders among 
non-specialist clinicians and the general public is leading to increasing referrals of individuals who report 
changes in memory and cognition to specialist services [11–13]. In a recent report from a memory clinic in 
Stockholm, 38% of patients were classified as having SCI [14]. Similarly, a recent survey of neurology-led UK 
memory clinics in 2014 suggested a mean of 27% of attendees had ‘benign memory complaints’ and the 
percentage has increased significantly over recent years. However, neurology-led clinics see predominantly 
younger patients and most memory assessment services in the UK are run by old age psychiatrists and 
geriatricians so further information about a wider range of memory services is required. The aim of this study is 
to determine levels of awareness about SCI as a construct in more typical specialist clinical practice in England 
and Wales (i.e., by memory clinics/services) and what clinicians do when faced with individuals meeting the 
criteria for SCI classification [3]. 
 
MATERIALS AND METHODS 
 
For this cross-sectional, service evaluation study, an email was distributed to every Royal College of 
Psychiatrists accredited memory clinic in England and to all the memory services in Wales. Within this email 
was a vignette (Table 1) describing a fictitious individual displaying typical signs of SCI. This vignette was 
accompanied by an open question asking what the memory service would do in this situation and closed 
questions relating to potential management options. Prior to this study, three memory clinic clinicians assessed 
this evaluation tool in order to validate the appropriateness of the questions and the accompanying vignette. The 
vignette was relatively sparse in order to encourage clinic-specific and a wide-range of responses. 
As replies could not be anonymized, all identifiable information from the email responses was removed before 
analysis. Thematic analysis was employed for the free text responses to the open question, which was realist 
driven, inductive, and bottom-up [16]. The responses were read and re-read by the principal investigator (AJ) 
who made initial comments and codes. The process was repeated twice more until individual codes were 
identified, and then grouped into themes in order to highlight commonalities among them. The code and theme 
development were subsequently checked by another member of the research team (AT). 
 
RESULTS  
 
Of 112 questionnaires sent out, 23 responses were received, representing a 21% response rate. Table 2 details 
responses to the first question about how teams would respond to patients with SCI. The identified themes and 
their relevant sub-themes are listed in descending order of response frequency. 
 
Theme One: ‘Action is dependent on’ 
 
This theme represents what the memory teams said would influence the actions they would take in managing 
someone like the ‘Mr X’ described in the vignette. Four sub-themes emerged, namely action would depend upon 
the patient’s premorbid ability and educational background, their activities of daily living (ADL), the presence 
of functional changes, and whether discrepancies between ADLs, functionality, and cognitive difficulties were 
identified. 
 
Theme Two: ‘Further investigations’ 
 
This theme represents what further investigations the memory teams would carry out if they were managing the 
case of ‘Mr X’. Seven sub-themes emerged: namely (1) the team would ensure an informant interview was 
carried out; (2) they would screen for reversible causes of SCI; (3) some clinicians reported that they would 
refer ‘Mr X’ for more comprehensive neuropsychological assessment; (4) they would refer ‘Mr X’ for a more 
comprehensive mental health assessment; (5) referral for further scanning; (6) referral to occupational therapy; 
and (7) requests for a patient to have a driving assessment. 
 
Theme Three: ‘Outcomes’ 
 
This theme is represented by six sub-themes and is related to the various outcomes patients experience, namely 
(1) most memory teams reported that they would reassure and discharge the individual if, after further 
investigation, no problems were identified; (2) many would reassure then discharge the individual and ask the 
GP to monitor and re-refer if problems persist or worsen; (3) they would arrange a follow up appointment; (4) 
the team would reassure, discharge, and signpost for additional support; (5) they would employ the strategy of 
‘watchful waiting’; and (6) some reported that they would not have initially even accepted the referral. 
 
Table 1 Vignette and questions distributed to memory clinics by email 
 
 
 
Mr X was referred to your clinic because he has noticed that he has developed some cognitive 
difficulties. He has no history of mental health problems, drug or alcohol misuse, and no history 
of vascular problems. He scored 29/30 on the MMSE, and 98/100 on the ACE-R. 
*Your responses will be confidential and anonymised* 
(1) As a team what would you do in this situation? 
 
 
(2) Please select which of the below applies to you and your team (you can select more than 
one) 
- generally reassure and discharge   yes/no 
- do not discharge, but employ an open door principle yes/no 
- diagnose them with subjective cognitive impairment  yes/no  
- routinely refer for detailed neuropsychological testing yes/no 
- routinely refer for a mental health assessment  yes/no 
- routinely refer for neuroimaging   yes/no 
- arrange future follow up for repeat assessment  yes/no 
- other   __________________________________ 
Table 2 Themes and sub-themes identified in response to question asking 
 
Theme Sub-themes 
1. Action is 
dependent on... 
- Premorbid ability and educational background 
- Activities of daily living (ADL) 
- Functional changes 
- Discrepancies between ADL/functionality and cognitive 
difficulties 
 
2.Further 
investigations 
- Informant interview 
- Screen for reversible causes of SCI 
- Neuropsychology assessment 
- Fuller mental health assessment 
- Further scanning 
- Refer to occupational therapy 
- Driving assessment  
 
3.Outcomes - Reassure and discharge if no problems identified after further 
investigations 
- Reassure, discharge, and ask GP to monitor and re-refer if 
problems persist or worsen 
- Follow up appointment arranged 
- Reassure, discharge, and signpost for additional support 
- Watchful wait 
- Would not initially even accept the referral  
 
4.Barriers  - Resources available 
- Shared care protocol 
- Commissioning regulations 
- Wanting to avoid making patient anxious 
 
 
 
Theme Four: ‘Barriers’ 
 
This is related to the difficulties teams face when managing their patients. Four sub-themes represent this theme. 
The first barrier identified was related to regarding the resources available to the team, e.g., staff numbers. 
Second, there are difficulties when some of the clinics have a shared protocol with another governing body, and 
third when they have shared commissioning regulations. Lastly, some reported that avoiding making the patient 
anxious would be a barrier with respect to case management. 
Table 3 shows the responses to the closed questions that the memory team selected regarding the management 
of the fictitious case of ‘Mr X’. Five of the 23 clinics that responded did not complete any questions in this 
section. A patient being ‘gently reassured and discharged’ was the most frequently selected from the list at 67% 
(12 out of 18 clinics). A patient being ‘routinely referred for more detailed neuropsychological testing’ and also 
‘routinely referred for neuroimaging’ were both selected by 44% of the respondents (8 out of 18 clinics). A 
‘routine referral for a mental health assessment’ was selected by 24% of the respondents (4 out of 17 clinics), 
and 22% would ‘arrange a future follow up for a repeat assessment’ (4 out of 18 clinics). An open door policy 
would be in place (without being discharged) by 18% of the respondents (3 out of 17 clinics), and only 6% said 
that they would diagnose SCI (1 out of 17 clinics). 
 
Table 3 Responses to question concerning actions subsequent to the diagnosis of SCI 
 
 Number (%) of positive 
responses 
Gently reassure & discharge 12 (67) 
Do not discharge but employ an open 
door policy* 
3 (18) 
Diagnose SCI* 1 (6) 
Routinely refer for more detailed 
neuropsychological testing 
8 (44) 
Routinely refer for mental health 
assessment* 
4 (24) 
Routinely refer for neuroimaging 8 (44) 
Arrange future follow up for repeat 
assessment  
4 (22) 
 
* n=17 
 
DISCUSSION 
 
The aim of this service evaluation was to explore the actions that memory clinics in England and Wales would 
take at the present time in response to the presentation of an individual with subjective memory or cognitive 
changes commensurate with the construct of SCI. 
It is clear that a relatively small proportion of responses were received and thus the outcome of this service 
evaluation should be interpreted accordingly, in that their responses may not be representative of all memory 
services in the UK. The reasons for this response rate are not known but to speculate it is possible that it 
represents a lack of ‘issue salience’ [17]. Thus the issue of SCI may not be deemed as an important one among 
clinical teams at present, despite this being an area of growing research importance and of concern to patients. 
Alternatively, response was simply precluded due to workload pressure and greater priorities.  
It is, however, also clear that the actions of the clinics that responded were highly variable. For instance, very 
little consensus was evident regarding the most likely outcome for SCI patients across different clinics. For 
example, our survey revealed that while some would carry out further investigations and then reassure and 
discharge if no problems were identified, others would routinely arrange a follow-up appointment, while some 
would not even have accepted such a referral in the first place. One can argue therefore that such heterogeneity 
in response urgently needs addressing in order to ensure continuity of care across the National Health Service. 
Neither MCI nor SCI are within the Diagnostic and Statistical Manual 5 (DSM-5) or the International 
Classification of Diseases 10 (ICD-10). This is likely to contribute to the lack of clarity and understanding about 
these diagnostic categories.  
Furthermore, the action taken by a clinic was also mediated by presenting features not mentioned in the vignette, 
but predictable all the same, namely premorbid ability and educational background, and whether or not they had 
experienced changes in their ADL or functional changes, i.e., a similar strategy to that applied to MCI. 
Additional assessments were also reported. Most frequently mentioned was the requirement for an informant 
interview, with some reporting that they would screen for potentially reversible causes of SCI not covered in the 
vignette. Due to a lack of clarity regarding what was causing ‘Mr X’s’ cognitive difficulties, a number of clinics 
said that they would seek additional information using neuropsychological assessment and further 
neuroimaging, whereas others reported that they would routinely perform such levels of assessment. Despite the 
vignette stating that ‘Mr X’ had no history of mental health problems, only some of the clinics said that they 
would refer the patient for a more comprehensive mental health assessment. Least frequently mentioned were 
referrals to occupational therapy and driving assessments. It is clear, therefore, that little consistency regarding 
the outcomes for people with SCI occurs in practice. 
Finally, a number of difficulties were identified which may act as barriers to the management of SCI. 
Fundamentally the main difficulty for clinics is the lack of resources, specifically staff numbers and available 
hours to take on a greater workload. Some clinics had difficulties associated with shared protocols and 
commissioning regulations, and others reported that they were concerned that investigations may invoke 
unnecessary anxiety in individuals reporting SCI if they were not showing signs of objective impairment. 
It is clear from these findings that the way SCI is managed across various memory clinics is heterogeneous. 
Lack of coherence is not generally considered to be best clinical practice, and is therefore indicative of urgent 
attention. For instance, a patient showing signs of SCI in one area of the UK may be referred to their local 
memory team, receive a full investigation with follow up appointments. Elsewhere, a similar patient referral will 
not even be accepted by the memory team, in which case it is possible that potentially reversible etiology will 
not be investigated further. Thus there appears to be a need for national guidance on the response to individuals 
presenting with SCI.  
From those who responded, the identification of themes and sub-themes suggests three key messages for all 
those who are likely to be involved in the management of someone with cognitive difficulties. 
 
Thorough investigation 
 
Five respondents stated that they would need further information prior to making any decisions regarding best 
course of action, with a minority reporting that they would carry out additional investigations and explore the 
patient’s concerns further, with additional neuropsychological testing and/or neuroimaging (8 out of 18 
respondents). Emphasis was placed on seeking further information from an informant, such as a close family 
member. The many potential factors associated with SCI [15, 18] justify a thorough specialist assessment in a 
memory clinic, with the aim of identifying what the problem is, its etiology, whether it can be treated, and how 
it can be managed. Ten out of the 18 respondents said they would not do additional investigations such as 
neuropsychological testing or neuroimaging. Only a minority (4 out of 18 respondents) of services would follow 
up a patient with SCI, but this may be due to limited resources and the need to prioritize activity by focusing on 
those with greatest cognitive and functional deficits. 
 
Using the term SCI 
 
Only one service out of 17 currently make a diagnosis of SCI or attempt to diagnose individuals who complain 
of changes in memory/cognition, but it is unclear if this is due to lack of familiarity with the term, or a 
reluctance to endorse a patient’s subjective complaints with a diagnostic label. Certainly emotional distress 
related to cognitive symptoms may be minimized if concerns are validated and not disregarded. 
Given the growing interest in SCI as an early presentation of impending dementia, use of the term for diagnosis 
will help to promote necessary research and may have future personal and societal benefits if effective 
preventive strategies are developed. 
 
Table 4 Best practice recommendations for people presenting with SCI 
 
1. Premorbid ability and educational background must be taken into account 
2. Activities of daily living (ADL) and functional changes should be assessed  
3. Discrepancies between ADL/functionality and cognitive difficulties should be a 
cause for concern and investigated further 
4. Further investigations such as detailed neuropsychological testing, neuroimaging 
and/or mental health assessment should be carried out if required  
5. An informant interview should be an essential feature of the assessment process 
6. All possible reversible causes of SCI should be assessed and treated if identified 
7. Follow-up appointment should be offered to assess changes, or an open door 
policy with easy access should be implemented if patient, family or general 
practitioner have any new concerns in the future  
 
 
Consistent approach to assessment and management is desirable 
 
There was no agreement on the appropriateness of further investigations or follow up of people with SCI. 
A lack of consistency is generally not regarded as best practice and best practice recommendations would seem 
appropriate. Based on the study responses, our provisional best practice recommendations are presented in Table 
4. 
To conclude, we aimed to explore what strategies were in place in memory services in the UK for someone 
displaying signs of SCI. The findings highlight a rather urgent need for a coherent and consistent framework to 
be introduced for the management of SCI. Three central messages have been put forward based on the themes 
and sub-themes identified. What is also clear is that several years ago the concept of MCI was the topic of 
similar debate to that surrounding SCI today and that MCI is now a widely recognized clinical diagnosis. As 
SCI may represent an increased risk factor for both MCI and dementia we argue that its clinical investigation 
and management be addressed more fully and a timely consensus reached. 
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